See more : CAD/JPY (HSIL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Ginko International Co., Ltd. (8406.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ginko International Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Chicken Soup for the Soul Entertainment, Inc. (CSSEP) Income Statement Analysis – Financial Results
- The Liberty SiriusXM Group (LSXMK) Income Statement Analysis – Financial Results
- Erie Indemnity Company (ERIE) Income Statement Analysis – Financial Results
- United States Cellular Corporat (UZE) Income Statement Analysis – Financial Results
- GS Engineering & Construction Corporation (006360.KS) Income Statement Analysis – Financial Results
Ginko International Co., Ltd. (8406.TWO)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: https://www.ginkointernational.com
About Ginko International Co., Ltd.
Ginko International Co., Ltd. manufactures and sells non-disposable and disposable contact lenses, and lens care products in China, Germany, the United Kingdom, Australia, Poland, Canada, Brazil, Iran, and internationally. It offers various optical products, such as high definition contact lenses, toric lenses, cosmetic lenses, and others, as well as lens solutions under the Horien and Hydron brands. Ginko International Co., Ltd. was incorporated in 2007 and is based in Taichung City, Taiwan.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.90B | 7.33B | 8.18B | 7.39B | 5.95B | 6.54B | 6.10B | 5.78B | 4.88B | 3.81B | 3.24B | 2.43B | 2.09B |
| Cost of Revenue | 4.33B | 3.33B | 3.73B | 3.48B | 2.72B | 2.62B | 2.42B | 2.31B | 1.89B | 1.37B | 1.18B | 866.70M | 824.54M |
| Gross Profit | 4.57B | 4.00B | 4.45B | 3.91B | 3.22B | 3.91B | 3.68B | 3.47B | 2.99B | 2.43B | 2.06B | 1.57B | 1.27B |
| Gross Profit Ratio | 51.35% | 54.55% | 54.37% | 52.93% | 54.21% | 59.86% | 60.40% | 60.07% | 61.26% | 63.95% | 63.65% | 64.40% | 60.63% |
| Research & Development | 195.39M | 194.32M | 192.63M | 139.67M | 124.32M | 103.65M | 110.80M | 79.46M | 63.47M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 679.12M | 672.66M | 699.19M | 635.89M | 706.09M | 698.18M | 635.83M | 640.21M | 548.70M | 408.13M | 397.26M | 246.73M | 216.23M |
| Selling & Marketing | 2.66B | 1.98B | 2.01B | 1.81B | 1.25B | 1.10B | 948.38M | 969.41M | 875.46M | 779.71M | 666.16M | 595.77M | 472.15M |
| SG&A | 3.34B | 2.65B | 2.71B | 2.44B | 1.96B | 1.80B | 1.58B | 1.61B | 1.42B | 1.19B | 1.06B | 842.49M | 688.38M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.53B | 2.85B | 2.90B | 2.58B | 2.08B | 1.90B | 1.70B | 1.69B | 1.49B | 1.19B | 1.06B | 842.49M | 688.38M |
| Cost & Expenses | 7.86B | 6.18B | 6.63B | 6.06B | 4.81B | 4.53B | 4.11B | 4.00B | 3.38B | 2.56B | 2.24B | 1.71B | 1.51B |
| Interest Income | 86.93M | 101.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 139.17M | 183.23M | 253.48M | 181.97M | 150.62M | 98.81M | 89.62M | 84.45M | 44.21M | 0.00 | 49.92M | 0.00 | 0.00 |
| Depreciation & Amortization | 879.59M | 869.91M | 799.30M | 605.64M | 538.15M | 535.39M | 459.27M | 378.93M | 257.03M | 176.37M | 135.81M | 106.60M | 93.83M |
| EBITDA | 2.11B | 2.31B | 2.61B | 2.03B | 1.86B | 2.47B | 2.41B | 2.19B | 1.90B | 1.43B | 1.15B | 774.38M | 622.57M |
| EBITDA Ratio | 23.75% | 31.46% | 31.86% | 27.51% | 31.24% | 37.83% | 39.48% | 37.94% | 38.88% | 37.46% | 35.56% | 31.80% | 29.72% |
| Operating Income | 1.23B | 1.15B | 1.55B | 1.33B | 1.14B | 2.01B | 1.99B | 1.78B | 1.50B | 1.25B | 997.66M | 725.70M | 581.63M |
| Operating Income Ratio | 13.86% | 15.68% | 18.94% | 18.00% | 19.21% | 30.76% | 32.61% | 30.86% | 30.77% | 32.74% | 30.81% | 29.80% | 27.77% |
| Total Other Income/Expenses | -138.96M | 107.07M | 4.72M | -98.19M | 14.72M | -177.45M | -129.90M | -53.58M | 94.79M | 3.35M | -31.71M | -57.92M | -52.89M |
| Income Before Tax | 1.10B | 1.26B | 1.55B | 1.23B | 1.16B | 1.83B | 1.86B | 1.73B | 1.60B | 1.25B | 965.95M | 667.78M | 528.74M |
| Income Before Tax Ratio | 12.30% | 17.14% | 18.99% | 16.68% | 19.46% | 28.05% | 30.48% | 29.93% | 32.71% | 32.83% | 29.83% | 27.43% | 25.24% |
| Income Tax Expense | 138.69M | 258.98M | 354.06M | 411.49M | 198.51M | 322.79M | 291.84M | 284.13M | 175.90M | 197.80M | 174.54M | 111.21M | 113.01M |
| Net Income | 956.44M | 993.78M | 1.20B | 833.38M | 971.04M | 1.52B | 1.57B | 1.45B | 1.42B | 1.05B | 791.41M | 556.57M | 415.74M |
| Net Income Ratio | 10.75% | 13.56% | 14.66% | 11.28% | 16.32% | 23.20% | 25.69% | 25.02% | 29.11% | 27.63% | 24.44% | 22.86% | 19.85% |
| EPS | 8.90 | 10.19 | 12.32 | 8.56 | 10.00 | 15.63 | 16.14 | 14.89 | 14.92 | 11.52 | 9.62 | 6.64 | 4.96 |
| EPS Diluted | 8.90 | 10.19 | 12.32 | 8.56 | 9.82 | 15.34 | 15.77 | 14.52 | 14.61 | 11.44 | 9.62 | 6.64 | 4.96 |
| Weighted Avg Shares Out | 107.49M | 97.48M | 97.39M | 97.35M | 97.07M | 97.07M | 97.07M | 97.16M | 95.17M | 91.32M | 82.26M | 83.84M | 83.79M |
| Weighted Avg Shares Out (Dil) | 107.49M | 97.48M | 97.39M | 97.35M | 98.89M | 98.87M | 99.36M | 99.65M | 97.23M | 91.90M | 82.26M | 83.84M | 83.79M |
Source: https://incomestatements.info
Category: Stock Reports